U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 1% on Monday.

Shares of Novo Nordisk A/S (NYSE:NVO) fell sharply in pre-market trading after the company released topline results from Phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly Cagrisema (Cagrilintide and Semaglutide).

Novo Nordisk shares dipped 4.8% to $41.15 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Aligos Therapeutics Inc (NASDAQ:ALGS) fell 15.1% to $4.45 in pre-market trading.
  • Telix Pharmaceuticals (NASDAQ:TLX) fell 7.9% to $11.60 in pre-market trading. Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE.
  • Perspective Therapeutics Inc (NYSE:CATX) fell 7.3% to $2.67 in pre-market trading.
  • Stewards Inc (NASDAQ:SWRD) declined 7% to $2.00 in pre-market trading.
  • Li Auto Inc (NASDAQ:LI) fell 3.5% to $11.72 in pre-market trading. Li Auto, last week, announced the launch of its flagship Li i9 SUV, priced at RMB369,800 for its standard configuration.
  • New Pacific Metals Corp (NYSE:NEWP) fell 3.3% to $5.80 in pre-market trading.
  • Inventiva SA – ADR (NASDAQ:IVA) declined 2.7% to $3.68 in pre-market trading.

Photo via Shutterstock